A review of the cost of cardiovascular disease

Area of Science:

• Public Health
• Health Economics
• Epidemiology

Background:

• Cardiovascular disease (CVD) accounted for 33% of all deaths in Canada in 2003, highlighting its significant public health impact.
• CVD represents a major economic burden on healthcare systems due to its high treatment costs.

Purpose of the Study:

• To review the literature on the economic costs of CVD in Canada and other developed nations.
• To synthesize findings on CVD economic burden from studies published between 1998 and 2006, with a focus on Canadian data.

Main Methods:

• A literature review was conducted, screening 1656 titles and abstracts.
• 34 articles were selected for detailed review, including six Canadian and 17 American studies.

Main Results:

• Studies showed considerable variation in reported economic costs.
• All reviewed studies indicated that the costs of treating CVD-related conditions are significant.

Conclusions:

• The substantial economic burden of CVD underscores the importance of investing in prevention programs.
• Evidence supports the implementation of effective CVD prevention strategies to mitigate healthcare costs.